CF
IBB icon

Centaurus Financial’s iShares Biotechnology ETF IBB Stock Holding History

Centaurus Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$102K – 670
2020
Q2 		$102K Buy
+10,000
New +$1.27M 0.02% 598

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centaurus Financial's IBB Position: Q1 2026 in Review

Centaurus Financial opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 903 shares worth $152K. The stake represents 0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: Centaurus Financial previously reported a position in IBB as recently as Q2 2024.

Centaurus Financial first reported a position in IBB in Q4 2017 and has held it in 28 quarters since. The position peaked at $509K in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Centaurus Financial held 903 shares of iShares Biotechnology ETF worth $152K as of Q1 2026.
  • iShares Biotechnology ETF was a new Centaurus Financial position in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of Centaurus Financial's portfolio in Q1 2026, its #909 holding.
  • Centaurus Financial first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 28 quarters since.
  • Centaurus Financial's iShares Biotechnology ETF position peaked at $509K in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.